logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore

prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Rossari Biotech Ltd

Rossari Biotech

Small Cap535 EmployeesIPO 2020
Current Price
446.30
-6.95 (-1.53%)Updated
NSE :ROSSARI
BSE :543213
Sector :Chemicals
Today's Range
443.05
446.30
indicator
455.6
52 Week Range
52W Low451.25
52W High766.00
446.30
indicator
Downside-1.10%
Upside71.63%

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
2,863.32 Cr
Market Cap
Total market value of company
P/E Ratio
20.67
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
2.74
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
24.84
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
5.85%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
15.80%
ROCE
Return on Capital Employed. >15% is good
Net Margin
6.01%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
13.91%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
28.23%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
17.60%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
4.39%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.18
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
214.12
Book Value
Net asset value per share
Dividend Yield
0.10%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
68.20%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • ROE 12.20% and ROCE 15.80% indicate strong operational efficiency and profitability.
  • Substantial 68.2% promoter holding reflects strong insider confidence and management alignment.

Weaknesses

5 points
  • Significant stock volatility, 52-week range ₹568-₹885, indicates considerable price risk.
  • Very low dividend yield of 0.08% may not appeal to income investors.

Opportunities

5 points
  • Positioned in dynamic Specialty Chemicals sector, capitalizing on increasing demand and expansion.
  • Market capitalization ₹3632 crore offers significant room for market share growth.

Threats

5 points
  • Operates in a highly competitive Specialty Chemicals market, limiting pricing power.
  • Inconsistent net profits in prior periods pose a risk to earnings stability.

Segment-wise Financial Analysis

Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

No insider trading data available

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4478.68+₹32.38+7.26%
R3466.13+₹19.83+4.44%
R2460.87+₹14.57+3.26%
R1453.58+₹7.28+1.63%
PIVOT448.322.020.45%
CURRENT446.30--
S1415.93-₹30.37-6.80%
S2428.48-₹17.82-3.99%
S3435.77-₹10.53-2.36%
S4441.03-₹5.27-1.18%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
0.56L
(13 Mar 2026)
+46.9% vs avg
Delivery %
65.7%
(13 Mar 2026)
+10.4% vs avg
Avg Volume (20D)
0.38L
(13 Feb - 13 Mar)
20-day average
Avg Delivery %
55.2%
(13 Feb - 13 Mar)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Asian Paints Ltd
2.34L ₹ Cr
Best Profit Growth
Yasho Industries Ltd
248.00 %
Highest Dividend Yield
Vidhi Specialty Food Ingredients Ltd
2.91 %

Peer Comparison

Company Name
ADVENZYMES
Advanced Enzyme Technologies Ltd
ASIANPAINT
Asian Paints Ltd
CAMLINFINE
Camlin Fine Sciences Ltd
FCL
Fineotex Chemical Ltd
FOSECOIND
Foseco India Ltd
JUBLCPL
Jubilant Agri & Consumer Products Ltd
KIRIINDUS
Kiri Industries Ltd
NEOGEN
Neogen Chemicals Ltd
RPEL
Raghav Productivity Enhancers Ltd
SHK
S H Kelkar & Company Ltd
TATVA
Tatva Chintan Pharma Chem Ltd
VIDHIING
Vidhi Specialty Food Ingredients Ltd
XPROINDIA
XPRO India Ltd
YASHO
Yasho Industries Ltd

About

ROSSARI

Rossari Biotech Ltd

Rossari Biotech Limited is a prominent Indian manufacturer and seller of specialty chemicals, serving both domestic and international markets. Their diverse portfolio encompasses a wide range of applications, showcasing their extensive capabilities within the chemical industry. This breadth allows them to cater to various sectors, demonstrating adaptability and a strategic focus on multiple revenue streams. The company's operational structure is built on a foundation of manufacturing and direct sales, giving them direct control over the production process and market access.

A significant portion of Rossari's business is dedicated to the production and distribution of chemicals for the soap and detergent industry. This is a substantial market segment, and Rossari's presence indicates their competitiveness and ability to meet the demands of this sector. Beyond detergents, they supply chemicals for inks, paints, coatings, ceramics, tiles, pulp and paper production, and cement manufacturing, highlighting the versatility of their chemical offerings and their significant contribution to several essential industrial processes.

Rossari further distinguishes itself through its specialized textile chemical offerings. This segment showcases a deep understanding of the textile industry's diverse needs. They provide chemicals tailored for various fabric types including cotton, polyester, acrylic, wool, silk, and nylon, demonstrating expertise in diverse textile processing techniques. Their commitment extends to functional finishes, denim processing, printing, and environmentally sustainable solutions, reflecting a focus on innovation and meeting contemporary industry demands.

In addition to its industrial chemical production, Rossari has expanded into consumer goods with its line of pet grooming products. These products, marketed under the brands Lozalo, Hunger Fills, and Sniffy, include shampoos, powders, deodorants, sprays, creams, and floor washing liquids. This diversification demonstrates a strategy to broaden their market reach and tap into consumer demand for pet care products. The company also produces poultry nutrition products, including vitamin-mineral formulations, enzyme blends, and herbal supplements, indicating expansion into the agricultural sector and the growing market for animal nutrition.

Founded in 1997 and headquartered in Mumbai, Rossari Biotech has evolved significantly since its inception as Rossari Labtech. The company's continuous growth and diversification illustrate a commitment to innovation, market expansion, and a strong understanding of various industry needs. Their success hinges on their ability to adapt to market trends and deliver high-quality chemical solutions for various sectors, ranging from industrial manufacturing to consumer products.

COMPANY FACTS - ROSSARI

Registered Address

Lbs Marg, Next To Ge Gardens, Kanjurmarg (W),, 201-A & B, Ackruti Corporate Park

Mumbai

MAHARASHTRA

IN

Tel: 912261233800

Website:https://www.rossari.com/

Company Details

Group: Materials

Sector: Materials

Industry: Chemicals

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 535

IPO Date: 23/07/2020

MANAGEMENT - ROSSARI

Mr. Edward Menezes

Executive Chairman of the Board, Co-Founder

Mr. Sunil Chari

Managing Director, Co-Founder, Executive Director

Mr. Ketan Sablok

Group Chief Financial Officer

Ms. Parul Gupta

Head- Company Secretary & Legal

Ms. Esha Achan

Non-Executive Independent Director

Mr. Gurudas Aras

Non-Executive Independent Director

Mr. Aseem Dhru

Non-Executive Independent Director

Ms. Aparna Sharma

Non-Executive Independent Director

Investor Questions Answered

Rossari Biotech Ltd (ROSSARI) Stock FAQs

Get answers to the most common questions about Rossari Biotech Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Rossari Biotech Ltd (ROSSARI) is ₹446.3. Today, the stock has declined by ₹6.95 (1.53%), trading in a range of ₹443.05 to ₹455.6. The stock opened at ₹451 with a trading volume of 55,654 shares.
Rossari Biotech Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,863.32 crores, P/E ratio of 20.67, ROE of 5.85%, and ROCE of 15.80%. The dividend yield stands at 0.10%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Rossari Biotech Ltd (ROSSARI) is ₹766, while the 52-week low is ₹451.25. Currently trading at ₹446.3, the stock is -1.6% away from its 52-week low and 41.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Rossari Biotech Ltd stock at ₹446.3 depends on multiple factors. The stock is currently trading with a P/E ratio of 20.67 and P/B ratio of N/A. Today's performance shows a loss of 1.53%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Rossari Biotech Ltd offers a dividend yield of 0.10%, which means for every ₹100 invested at the current price of ₹446.3, you can expect to receive approximately ₹0.10 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Rossari Biotech Ltd's key financial metrics include: P/E Ratio: 20.67, P/B Ratio: N/A, ROE: 5.85%, ROCE: 15.80%, Dividend Yield: 0.10%, EPS: ₹24.84, Book Value: ₹214.12, Debt-to-Equity: 0.18, and Current Ratio: N/A. The company's market cap stands at ₹2,863.32 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Rossari Biotech Ltd stock opened at ₹451 and is currently trading at ₹446.3, showing a decline of ₹6.95 (1.53%). The intraday high is ₹455.6 and low is ₹443.05. The trading volume stands at 55,654 shares, indicating moderate market participation today.
Rossari Biotech Ltd has a Price-to-Earnings (P/E) ratio of 20.67, which means investors are willing to pay ₹20.67 for every ₹1 of earnings. With an EPS of ₹24.84, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
Rossari Biotech Ltd has a market capitalization of ₹2,863.32 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹446.3) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Rossari Biotech Ltd has a book value of ₹214.12 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹446.3, which is 108.4% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Rossari Biotech Ltd has a Return on Equity (ROE) of 5.85% and Return on Capital Employed (ROCE) of 15.80%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Rossari Biotech Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Rossari Biotech Ltd has a debt-to-equity ratio of 0.18, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Rossari Biotech Ltd has an Earnings Per Share (EPS) of ₹24.84, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹446.3 and P/E ratio of 20.67, investors are paying 20.67 times the annual earnings per share. This moderate EPS suggests decent earnings generation. Track EPS growth over quarters to assess earnings momentum.
Rossari Biotech Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Rossari Biotech Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Rossari Biotech Ltd stock, consider: 1) Fundamental Analysis - Review P/E (20.67), ROE (5.85%), debt-to-equity (0.18), and growth rates. 2) Technical Analysis - Check 52-week range (₹451.25 - ₹766.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹446.30) with book value (₹214.12) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Rossari Biotech Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹446.3 is 22215x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Rossari Biotech Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹451.25 - ₹766.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.18 indicates leverage. 4) Liquidity Risk - Based on trading volume of 55,654 shares. 5) Valuation Risk - P/E of 20.67 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Rossari Biotech Ltd operates in the industry with key metrics: P/E ratio of 20.67, ROE of 5.85%, market cap of ₹2,863.32 crores, and dividend yield of 0.10%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.18), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Rossari Biotech Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹446.3, with a 52-week range of ₹451.25 to ₹766.00. Based on fundamentals like P/E (20.67), ROE (5.85%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Rossari Biotech Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹446.30. 2) Fundamental Deterioration - Declining ROE (currently 5.85%), increasing debt (D/E: 0.18), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Rossari Biotech Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.10%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.